“Ascend Fingol: Capsules with Failed Dissolution Specifications Recalled.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33376-ascend-fingol-capsules-with-failed-dissolution-specifications-recalled. Based on FDA recall #D-0925-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0925-2023%22&limit=1).
The FDA announced on July 11, 2023, that Ascend Laboratories, LLC voluntarily recalled Fingolimod Capsules due to failed dissolution specifications. The recall affects 2,652 bottles distributed nationwide.
The product failed dissolution specifications, according to the FDA. The recall is classified as Class II.
Context
GovInfoNow's records show Ascend Laboratories, LLC has 35 other recalls on record since November 2, 2016. Other recent recalls of similar products include Inventia Chlorthalidone Recall (September 3, 2026), Sun Pharmaceutical Lisdexamfetamine Capsules Recall (October 28, 2025), and AvKARE Amantadine Capsules Recall (February 13, 2026).
How to tell if you have this one
Check for the 0.5 mg Fingolimod capsules (30-count bottle) with NDC 67877-476-30. The lot number is 22122841, expiring August 2025.
Brand
Ascend Laboratories
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Medication Details
Verify the product label shows NDC 67877-476-30 and lot number 22122841.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 15 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0925-2023 (July 11, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0925-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.